LncRNA FOXD2‐AS1 as a competitive endogenous RNA against miR‐150‐5p reverses resistance to sorafenib in hepatocellular carcinoma
Chengjun Sui(Second Military Medical University), Minhui Xu(Suzhou Municipal Hospital)
Cited by 40
Related Papers
Comprehensive analysis of spatial architecture in primary liver cancer
|Science Advances|2021|359
Trajectory and Functional Analysis of PD‐1<sup>high</sup> CD4<sup>+</sup>CD8<sup>+</sup> T Cells in Hepatocellular Carcinoma by Single‐Cell Cytometry and Transcriptome Sequencing
|Advanced Science|2020|107
Discovery of a Carbamoyl Phosphate Synthetase 1–Deficient HCC Subtype With Therapeutic Potential Through Integrative Genomic and Experimental Analysis
|Hepatology|2021|65
Comprehensive Analysis of Spatial Architecture in Primary Liver Cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2021|41
LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma cell proliferation and resistance to apoptosis by targeting miR-4656/HDAC11 axis
|Cancer Cell International|2020|30